|
Dr. Gregory Berk joined us as chief medical officer in May 2007. An oncology veteran with more than 23 years of experience Dr. Berk was most recently senior vice president and chief medical officer for Hana Biosciences a San Francisco-based oncology company. Previously he was medical director for the Network of Medical Communications and Research a consulting and medical education company focused on clinical-stage oncology research. Dr. Berk was an attending physician in the Department of Medicine at New York Presbyterian Hospital (Cornell Campus) and an assistant professor of medicine at the Weill Medical College of Cornell University where he was an investigator in numerous oncology clinical trials including the pivotal trials for Gleevec as well as colorectal and breast cancer trials for Avastin and a number of CALGB studies. Dr. Berk holds a medical degree from Case Western Reserve University School of Medicine in Cleveland Ohio . He began his undergraduate studies in biochemistry at Cambridge University in Cambridge England and graduated summa cum laude from Tulane University in New Orleans Louisiana . Dr. Berk completed his internship residency and fellowship at The New York Hospital Cornell Medical Center . He is Board certified in internal medicine and medical oncology and is a member of the American Society of Hematology and the American Society of Clinical Oncology. | 